Abiologics
Focus: Abiologics is a Cambridge-based public biotechnology company founded in 2000 specializing in synteins with a focus on neurology and infectious diseases. The company operates as a mid-cap biotech player with a lean, research-driven operation.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
2
Should You Work at Abiologics?
AI assessmentAbiologics offers scientifically interesting work in focused areas but poses execution risk due to absent clinical pipeline and minimal open headcount.
Why Work Here
- Established 24-year history in biotech with public-company infrastructure and stability in Cambridge biotech hub
- Focused pipeline in high-impact therapeutic areas (neurology and infectious diseases) offering meaningful scientific contribution
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Abiologics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.